National

The Food and Drug Administration has approved Reyvow, a new pill made by Eli Lilly that treats migraine attacks. The drugmaker did not immediately disclose the drug's price.

The big picture: Reyvow is not approved for the prevention of migraines, but other new drugs on the market — Aimovig, Ajovy and Emgality — are described as preventative for migraines.

FDA approves another new migraine medicine

But the new drug, Reyvow, does not prevent migraines.

A phone with the Eli Lilly logo on the screen.

Eli Lilly has two prominent migraine drugs now. Photo: Igor Golovniov/SOPA Images/LightRocket via Getty Images

Health Care

Pharmaceutical industry

Business

The Food and Drug Administration has <a class="gtmContentClick" data-vars-link-text="approved" data-vars-click-url="https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-patients-migraine" data-vars-content-id="ff3e7e13-1eff-49b9-958e-ff4c080119e9" data-vars-headline="FDA approves another new migraine medicine" data-vars-event-category="story" data-vars-sub-category="story" data-vars-item="in_content_link" href="https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-patients-migraine" target="_blank">approved</a> Reyvow, a new pill made by Eli Lilly that treats migraine attacks. The drugmaker did not immediately disclose the drug&#x27;s price.The big picture: Reyvow is not approved for the prevention of migraines, but other new drugs on the market — Aimovig, Ajovy and Emgality — are described as preventative for migraines.

The U.S. faces a range of health care flashpoints — unaffordable drugs, opioids, vaping — as we debate whether to adopt universal care. For now, the Affordable Care Act is the law of the land, but Republicans want to issue it a final death blow.

FDA approves another new migraine medicine

Go deeper